动脉血管生成:对于胰腺癌的抗血管原性免疫疗法的含义
Adam W Beck1, Herbert Chen1, Bin Ren1
1Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, AL, USA.
Cytokine & growth factor reviews
|October 17, 2025
概括
动脉血管新生,新的小动脉的生长,由亲和抗血管新生信号的平衡来调节. 这种平衡影响疾病,并为新的癌症和心血管治疗提供信息.
科学领域:
- 心血管生物学 心血管生物学
- 在瘤学瘤学.
- 血管生物学 血管生物学
背景情况:
- 血管新生,新血管的形成,对于疾病的进展和解决至关重要.
- 动脉血管生成,特别是小动脉的生长,在病理状况中起着关键作用.
- 了解分子信号平衡对于控制血管性表型至关重要.
研究的目的:
- 定义动脉血管生成及其调节分子信号.
- 探索动脉动脉血管生成在病态微环境中的作用.
- 突出癌症干细胞发育的影响和新的治疗策略.
主要方法:
- 对血管新生现有文献的综述,重点关注动脉动脉血管新生.
- 讨论关键的信号通路,包括VEGF,CXCL12和Notch1-CD36.
- 分析动脉血管生成在癌症和心血管疾病中的作用.
主要成果:
- 一个基于分子信号平衡的动脉动脉血管生成的概念框架.
- 在血管内皮细胞中识别VEGF和CXCL12信号通路.
- 重点是PKD1-介导的Notch1-CD36信号在调节动脉动脉生成.
- 动脉血管生成在病理条件下起到关键的血管的作用.
结论:
- 动脉血管生成是一个关键的过程,受到信号平衡的影响,影响疾病.
- 对癌症干细胞发育和抗血管原性免疫疗法的影响很大.
- 新的血管向和免疫疗法可以开发用于血管生成相关疾病.
关键词:
抗血管原性免疫疗法 抗血管原性免疫疗法动脉血管生成 (Angiogenesis) 是一种动脉血管的形成.CD36 CD36 CD36 CD36 CD36 CD36 CD36 CD36 CD36 CD36 CD36 CD36 CD36 CD36在CXCL12 (SDF-1) 中.胰腺癌 胰腺癌瘤血管微环境 (TVME) 是指瘤血管微环境.在VEGF中,VEGF是VEGF.更多相关视频
09:03Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
1.6K
09:03Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
10.1K
相关概念视频
Mechanism of Angiogenesis
6.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.7K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
